( June 9, 2026, 12:42 PM EDT) -- WASHINGTON, D.C. — The U.S. Judicial Panel on Multidistrict Litigation (JPMDL) centralized cases alleging that Dupixent
XE "Dupixent" , a prescription medication used for the treatment of asthma and inflammatory skin conditions, causes cutaneous T-cell lymphoma (CTCL), a rare type of cancer that affects white blood cells called T cells or T lymphocytes....